Plasma EV profiling facilitates low abundance biomarker discovery in pancreatic cancer

被引：1
|
作者：
Bansal, Shivani
Wang, Shu
Li, Yaoxiang
Bansal, Sunil
Smith, Jill
Tyburski, John B.
Unger, Keith
Cheema, Amrita
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-1074
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1074
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Considerations for the use of plasma cytokeratin 18 as a biomarker in pancreatic cancer
    C Dive
    R A Smith
    E Garner
    T Ward
    S St George-Smith
    F Campbell
    W Greenhalf
    P Ghaneh
    J P Neoptolemos
    British Journal of Cancer, 2010, 102 : 577 - 582
  • [42] Plasma/serum proteomics: depletion strategies for reducing high-abundance proteins for biomarker discovery
    Lee, Pey Yee
    Osman, Junaida
    Low, Teck Yew
    Jamal, Rahman
    BIOANALYSIS, 2019, 11 (19) : 1799 - 1812
  • [43] Proteomic strategy for the identification of low abundance proteins and investigation of biomarker in human plasma
    Li, R.
    Dai, J.
    Zhou, H.
    Li, S.
    Jin, W.
    Xia, Q.
    Zeng, R.
    MOLECULAR & CELLULAR PROTEOMICS, 2005, 4 (08) : S212 - S212
  • [44] Profiling protease cleavage patterns in plasma for pancreatic cancer detection
    Stewart, Morgan R.
    Quentel, Arnaud
    Manalo, Elise
    Montoya Mira, Jose
    Ranganathan, Srivathsan
    Branchaud, Bruce P.
    Fischer, Jared M.
    Tu, Eugene
    Civitci, Fehmi
    Chiu, Yu-Jui
    Yildirim, Adem
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [45] A neural network approach to multi-biomarker panel discovery by high-throughput plasma proteomics profiling of breast cancer
    Fan Zhang
    Jake Chen
    Mu Wang
    Renee Drabier
    BMC Proceedings, 7 (Suppl 7)
  • [46] In vivo platform for translational drug development and biomarker discovery in pancreatic cancer.
    Hidalgo, M.
    Rubio-Viqueira, B.
    Weekes, C.
    Song, D.
    Shah, P.
    Messersmith, W.
    Messersmith, W.
    Altiok, S.
    Kulesza, P.
    Maitra, A.
    Jimeno, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 179S - 179S
  • [47] Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach
    Gronborg, M
    Kristiansen, TZ
    Iwahori, A
    Chang, R
    Reddy, R
    Sato, N
    Molina, H
    Jensen, ON
    Hruban, RH
    Goggins, MG
    Maitra, A
    Pandey, A
    MOLECULAR & CELLULAR PROTEOMICS, 2006, 5 (01) : 157 - 171
  • [48] Proof-of-Principle Biomarker Discovery Study Demonstrates That Changes in the Plasma Levels of Low Abundance Proteins Such as Endoglin Can Be Detected Using an Unbiased Global Discovery Approach
    Blankley, Richard T.
    Whetton, Anthony D.
    Baker, Philip N.
    Myers, Jenny E.
    REPRODUCTIVE SCIENCES, 2009, 16 (03) : 168A - 168A
  • [49] An Integrated Quantitative Proteomics Workflow for Cancer Biomarker Discovery and Validation in Plasma
    Kumar, Vipin
    Ray, Sandipan
    Ghantasala, Saicharan
    Srivastava, Sanjeeva
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [50] Biomarker discovery in plasma of breast cancer patients using microspot immunoassays
    Sonntag, J.
    Joecker, A.
    Schneeweiss, A.
    Wiemann, S.
    Korf, U.
    EJC SUPPLEMENTS, 2010, 8 (05): : 47 - 47
12345